1. Home
  2. PM vs AZN Comparison

PM vs AZN Comparison

Compare PM & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Philip Morris International Inc

PM

Philip Morris International Inc

HOLD

Current Price

$149.44

Market Cap

238.8B

Sector

Health Care

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$91.53

Market Cap

276.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PM
AZN
Founded
1987
1992
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.8B
276.3B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
PM
AZN
Price
$149.44
$91.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
2
Target Price
$190.44
N/A
AVG Volume (30 Days)
5.3M
5.5M
Earning Date
10-21-2025
11-06-2025
Dividend Yield
3.93%
1.68%
EPS Growth
N/A
45.02
EPS
5.52
6.02
Revenue
$39,992,000,000.00
$58,127,000,000.00
Revenue This Year
$10.82
$11.33
Revenue Next Year
$7.66
$6.08
P/E Ratio
$27.12
$15.20
Revenue Growth
7.45
13.52
52 Week Low
$116.12
$61.24
52 Week High
$186.69
$94.02

Technical Indicators

Market Signals
Indicator
PM
AZN
Relative Strength Index (RSI) 42.78 60.08
Support Level $146.65 $89.67
Resistance Level $150.89 $91.28
Average True Range (ATR) 3.22 1.45
MACD -0.60 -0.30
Stochastic Oscillator 25.97 55.58

Price Performance

Historical Comparison
PM
AZN

About PM Philip Morris International Inc

Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Share on Social Networks: